poisar

Stocks · News reference

Charles River Laboratories Recent $470 Million Deal an 'Attractive Strategic Addition,' Analyst Says

BenzingaVandana Singh

Charles River Laboratories will buy Frontage's bioanalysis unit for $470 million in cash to expand its clinical drug testing scale.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading